genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Artificial Intelligence
From Model to Molecule: NVIDIA Doubles Down on AI Drug Discovery
AgBio
Let There Be Light: GreenLight Strives for Global RNA Equity to…
Coronavirus
Icosavax: Giving VLPs the VIP Treatment
CRISPR
Inscripta Eyes Broader Genome Editing Reach with $150M Series E
Drug Discovery
You Can See Manhattan from Your Lab: $3B “Cove” Campus Announced…
News
Alzheimers
Mouse Model of Alzheimer’s Reveals Some Plaques May Defend and Not…
Biomarker Discovery
Genetic Markers Discovered that Open Door to Potential New Lung Cancer…
CRISPR-Cas9
Parallel Genome Editing in Microscopic Worms Maps Regulatory Genomic Elements to…
Drug Discovery
Heart Drug Reverses Obesity and Related Metabolic Disorders in Mice
Antibodies
Machine Learning Helps Optimize Therapeutic Antibodies
Insights
All
Trends for 2020
Trends for 2021
Antisense
n-Lorem Makes Ultrarare Disease Treatment Personal
Bioprocessing
Getting the Most Out of Your Intensified Bioprocess
Antibodies
Whence the Facility Expansions?
Bioprocessing
CDMOs Embrace Innovative Tech to Create “Digital Threads”
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
shire
shire
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
shire
Shire, Takeda Shareholders Approve $58.5B Acquisition Deal
shire
Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum
shire
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
shire
Shire, Takeda Come to Terms on $62B Acquisition Deal
shire
Shire Board Sets Stage for $64B Takeda Acquisition, If Companies Resolve Details
shire
Shire Rejects Takeda Takeover Bids
shire
Servier to Acquire Shire’s Oncology Business for $2.4B
shire
Shire Pursues FDA Approval for Plasma Manufacturing Facility
shire
Lonza Expands in Mammalian Manufacturing with Purchase of California Site
shire
Shire Transfers IND for GvHD Candidate to Kamada
shire
Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial
shire
Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results
shire
Shire, Parion Ink Deal for Up to $535M to Develop Phase...
shire
EC Approves Shire’s Recombinant Parathyroid Hormone for Hypoparathyroidism
shire
RaNA Therapeutics Acquires Shire’s mRNA Platform
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-265x198.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
